Cargando…

Commentary: “Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression”

Detalles Bibliográficos
Autores principales:	Fried, Eiko I., Boschloo, Lynn, van Borkulo, Claudia D., Schoevers, Robert A., Romeijn, Jan-Willem, Wichers, Marieke, de Jonge, Peter, Nesse, Randolph M., Tuerlinckx, Francis, Borsboom, Denny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543778/ https://www.ncbi.nlm.nih.gov/pubmed/26347663 http://dx.doi.org/10.3389/fpsyt.2015.00117

Ejemplares similares

Mental disorders as networks of problems: a review of recent insights
por: Fried, Eiko I., et al.
Publicado: (2016)

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
por: Hieronymus, F, et al.
Publicado: (2016)

Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential
por: Fried, Eiko I, et al.
Publicado: (2015)

The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
por: Boschloo, Lynn, et al.
Publicado: (2023)

The Impact of Individual Depressive Symptoms on Impairment of Psychosocial Functioning
por: Fried, Eiko I., et al.
Publicado: (2014)

The Network Structure of Symptoms of the Diagnostic and Statistical Manual of Mental Disorders
por: Boschloo, Lynn, et al.
Publicado: (2015)

A new method for constructing networks from binary data
por: van Borkulo, Claudia D., et al.
Publicado: (2014)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
por: Singh, A.N., et al.
Publicado: (2000)

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

A Network Approach to Psychopathology: New Insights into Clinical Longitudinal Data
por: Bringmann, Laura F., et al.
Publicado: (2013)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring
por: Olivier, J. D. A., et al.
Publicado: (2013)

Depression and the Use of Selective Serotonin Reuptake Inhibitors in Patients with Acute Intracerebral Hemorrhage
por: Syed, Maryam J, et al.
Publicado: (2019)

Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
por: Gök, Soner, et al.
Publicado: (2023)

Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
por: Margoob, Mushtaq A., et al.
Publicado: (2008)

Major Depression as a Complex Dynamic System
por: Cramer, Angélique O. J., et al.
Publicado: (2016)

Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice
por: Singh, Paramdeep, et al.
Publicado: (2015)

Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Brain Imaging Study on the Pathogenesis of Depression & Therapeutic Effect of Selective Serotonin Reuptake Inhibitors
por: Meng, Qi, et al.
Publicado: (2020)

Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
por: Kim, Hye-Geum, et al.
Publicado: (2019)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong, Zhuoyuan, et al.
Publicado: (2017)

Estimating psychological networks and their accuracy: A tutorial paper
por: Epskamp, Sacha, et al.
Publicado: (2017)

Data-driven subtypes of major depressive disorder: a systematic review
por: van Loo, Hanna M, et al.
Publicado: (2012)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
por: Kumar, Deepak, et al.
Publicado: (2009)

Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy
por: Dziurkowska, Ewelina, et al.
Publicado: (2013)

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder
por: Keating, Charlotte, et al.
Publicado: (2013)

Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes
por: Köhler, Ole, et al.
Publicado: (2015)

In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Yi, Julie, et al.
Publicado: (2022)

Level and timing of physical activity during normal daily life in depressed and non-depressed individuals
por: Minaeva, Olga, et al.
Publicado: (2020)

Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Qin, Sisi, et al.
Publicado: (2019)

A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
por: Coplan, Jeremy D., et al.
Publicado: (2014)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Effect of Electroacupuncture on Reuptake of Serotonin via miRNA-16 Expression in a Rat Model of Depression
por: Zhao, Jun, et al.
Publicado: (2019)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis
por: Richter, Daniel, et al.
Publicado: (2021)

Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor‐Treated Women
por: Mesches, Gabrielle A., et al.
Publicado: (2022)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study
por: Wongpakaran, Nahathai, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_df0b1k6q8da0uqbol1ufim4r67